Insights & Resources | Pfizer CentreOne

Highly Potent Oral Solids: Top Considerations

Understanding product classification and the heightened complexity of HPAPI drug substance transfer and manufacturing is critical. Developers are increasingly working with CDMOs to commercialize their HPAPIs. Kieran Coffey, Technical Services Lead at Pfizer CentreOne, discusses these key considerations

Experience the Art of Science - Debbie Lemons's story

In this instalment of our ‘Experience the Art of Science’ blog series, we meet Debbie Lemons, Senior Regulatory Compliance External Lead Auditor at our Rocky Mount facility.

Building More Resilient API Supply Chains

Safe, secure and reliable supply lines for key medicines is one of pharma's top priorities. However, as recent reports about shortages of active pharmaceutical ingredients (APIs) impacting on the supply of key medicines show, there are lessons to be learned to ensure optimum supply chain security.

How to Secure a Sustainable Supply of Raw Materials

There are a few steps pharmaceutical companies can take to minimize insecurity in their supply chain even in a rapidly changing market, find out what these are in this article.

Your Questions Answered - Highly Potent Oral Solids Q&A

Pfizer CentreOne’s OSD experts answer your questions following our recent webinar on the challenges and considerations for a highly potent oral solids project.

The path to a secure supply chain – 10 questions to ask

In this e-Book, Jim Carr, Operations Lead for APIs & Intermediates at Pfizer CentreOne discusses the 10 key questions to ask when diversifying your API supply chain and how our team of experts can work with you to achieve this.

Sitting Down With… Andrew Moore, General Manager of Pfizer CentreOne, Medicine Maker

Andrew Moore, GM of Pfizer CentreOne spoke to the Medicine Maker to discuss his leadership journey, his goals for the business and his leadership advice.

Webinar | Highly Potent Oral Solids: Challenges and Considerations

In this webinar Pfizer CentreOne’s oral solids (OSD) experts discuss key consideration highly potent oral solids (HPOSD), focusing on three key challenges faced during development and manufacture.

Case Study | Why The Right Partner is Key to Successful Drug Innovation

At Pfizer CentreOne, we are proud to collaborate with pioneering companies in navigating the drug development journey to bring their innovations to market and transform the lives of patients read about how we make it happen.

Experience the Art of Science - David Farrar's story

In our latest ‘Experience the Art of Science’ series, we meet David Farrar, Technology Specialist at our Newbridge facility and a piano player.

CPhI Discover: Embedding Responsible Manufacturing Practices across the Pharmaceutical Value Chain

Pfizer CentreOne’s API & Intermediates Business Lead, Andrew Anderson and Pfizer’s Vice President, Global Environment Health & Safety, Louise Proud, took part in a webinar for CPhI Discover to discuss natural resource efficiencies & the protection of future medicines supply.

Pfizer CentreOne Newsletter June 2021 Edition

In the latest edition of our newsletter, our bold API & Intermediates campaign, ‘In Your Corner’ takes center stage on the front cover and our Global Customer Engagement Marketing Senior Manager, Jennifer Griffin, discusses the inspiration behind the campaign.